Novo Nordisk Shares Plunge After New Obesity Shot Falls Short of Expectations — Update | Morningstar

Novo Nordisk Shares Plunge After New Obesity Shot Falls Short of Expectations — Update
By Peter Loftus and Dominic Chopping
An experimental Novo Nordisk anti-obesity treatment helped patients lose less than a quarter of their bodyweight in
Read more...